Professional Documents
Culture Documents
Antimicrobial Stewardship
Mediadora C. Saniel, MD, MBA-H
2019 PPHA National Covention
May 4, 2019
Davao City
Outline
• Rationale for antimicrobial stewardship
(AMS)
• AMS in the Philippines
• Role of pharmacists in current AMS program
• Expanding the role of pharmacists
Air pollution and climate change
Noncommunicable diseases
Global influenza pandemic
Fragile and vulnerable settings
Antimicrobial resistance
Ebola and other high-threat pathogens
Weak primary health care
Vaccine hesitancy
Dengue
HIV
AMR as a Global Public Health threat
• AMR kills
• AMR hampers the control of infectious diseases
• AMR increases the costs of health care
• AMR jeopardizes health care gains to society
• AMR has the potential to threaten health security,
and damage trade and economy
WHO fact sheet, 2011
Review on Antimicrobial Resistance 2014
Review on Antimicrobial Resistance 2014
The Antibiotic Resistance
Surveillance Program (ARSP)
• Very alarming rates of
resistance among various
pathogens
▫ Escherichia coli
▫ Klebsiella spp.
▫ Pseudomonas aeruginosa
▫ Acinetobacter spp.
▫ Streptococcus pneumoniae
▫ Staphylococcus aureus
▫ Neisseria gonorrheae
NATIONAL ANTIMICROBIAL STEWARDSHIP TRAINING WORKSHOP
Administrative Order no. 42 s. 2014
Office of the President
The Inter-Agency
Committee on AMR
(ICAMR)
Chairs:
DOH
DA
Members:
DTI
DILG
DOST
NATIONAL ANTIMICROBIAL STEWARDSHIP TRAINING WORKSHOP
The Philippine Action Plan to Combat AMR:
One Health Approach
ANTIMICROBIAL
Research and
STEWARDSHIP
Development
PROGRAM (PPS)
Pubmed citations on antimicrobial or antibiotic stewardship
over the past 20 years
Choice of antibiotic
To prevent or slow
RIGHT
Centers for Disease Control and Prevention. MMWR. March 2014. 63; 194-200.
NATIONAL AMS PROGRAM
25
Core Element 2: POLICIES,
GUIDELINES and CLINICAL PATHWAYS
• Antimicrobial usage/consumption
- provides critical information on the
antimicrobial prescribing/usage patterns within
the hospital and/or specific patient groups
- enables the institution and policymakers to
monitor the progress of AMS programs and assess
the impact of strategies/ interventions
DDD/1000 Patient Days of Antimicrobials
Restricted Non-Restricted
250
200
2015
DDD/1000 Patient Days
2016
150 2017
2018
100
50
Current Status
T Level III 100%
A (114/114)
R 85.50%
Level II
(283/331)
G
E Level I + 0%
(0/791)
T Others (Mother and Child,
Specialty)
Overall percentage of hospitals
Department of Health
trained: 32.12%
(397/1,236)
Antimicrobial Stewardship Program in Primary
• Adherence to AMS guidelines
• De-escalation
• Switching from IV to oral rx
• Therapeutic drug monitoring
• Antibiotics restriction
• Bedside consultation
show significant impact on clinical outcomes,
adverse events, costs, resistance rates, or
combinations of these
Department of Health
Antimicrobial Stewardship Training for Hospitals
2018
De-escalation of therapy based on culture
reduced mortality.
RRR= 56%
The majority of studies reported a positive effect of hospital
antibiotic stewardship interventions. However, we cannot draw
general conclusions about the effectiveness of such interventions
in low- and middle-income countries because of low study quality,
heterogeneity of interventions and outcomes, and under-
representation of certain settings.
• Undergrad/postgrad curricula
• Continuing prof’l educational activities
Pharmacist-Driven Antimicrobial Stewardship
A pharmacist-driven, prospective audit and feedback strategy for
antimicrobial stewardship in 47 urban/rural hospitals led to a
significant reduction in mean antibiotic consumption (DDD/ 100
patient-days) from 101.38 (9% CI 93.05-109.72) to 83.04 (74.87-
91.22)
Targeted process measures:
Cultures not done before starting empirical antibiotics
More than 7 days of antibiotic rx
More than 14 days of antibiotic rx
Use of >4 antibiotics concurrently
Redundant/double antibiotic coverage
Longitudinal cohorts survey of mean antibiotic consumption for three phases of the
Netcare antimicrobial stewardship model
No Time to Wait: Securing the future from drug-resistant infections. AICG. April 2019
One Health, IACG recommendations and the Sustainable Development Goals
No Time to Wait: Securing the future from drug-resistant infections. AICG. April 2019
DDD/1000 Patient Days of Antimicrobials
Restricted Non-Restricted
250
200
2015
DDD/1000 Patient Days
2016
150 2017
2018
100
50
Adapted from Dellit TH et al. Clinical Infectious Diseases 2007; 44:159-77; Barlam TF et al. Clinical Infectious Diseases 2016; 62:51 -77
Two core ASP strategies have evolved:
ACTIVE INTERVENTIONS
• Clinical rounds discussing clinical cases, morbidity & mortality meetings,
significant event analysis/reviews
• Prospective audit with intervention and feedback
• Reassessment of antibiotic prescriptions, with streamlining and de-
escalation
• Academic detailing, educational outreach visits
• E-learning resources used as individual or group activities can compliment
traditional learning methods, as a “blended learning” approach
PATIENTS
HEALTH
PROFESSION
ALS
INDUST
RY